OrthoEvidence Trial Assessing Japanese Knowledge Updates

Study Overview
=================
Brief Summary
-----------------
The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

Detailed Description
-----------------
The investigators will conduct the survey regarding baseline characteristics, barriers and familiality to evidence-based medicine by online. After the survey, the participants will be randomly assigned to receive either the original version of ACE reports or Japanese version of ACE reports. The pdf of each ACE report will be provided to the participants through an email link. Twenty reports will be sent over 4 weeks period. After that, the investigators will conduct another survey regarding the reports.

Official Title
-----------------
OrthoEvidence Trial Assessing Japanese Knowledge Updates : Trial of Knowledge Translation Among Japanese Surgeons

Conditions
-----------------
Healthy Volunteer

Intervention / Treatment
-----------------
* Other: Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
* Other: English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Member of Japanese Society for Fracture Repair (JSFR) Spend at least 20% of their time in clinical practice Non-native speaker of English Has regular access to internet Prefer to read Japanese-translated material, if there are both translated and English version of the same material. Exclusion Criteria: We will exclude surgeons who cannot provide informed consent.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Japanese group<br>Participants who will receive Japanese-translated version of evidence summaries | Other: Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)<br>* Participants will receive emails with the link to Japanese-translated version of evidence summaries.<br>|
| Active Comparator: English group<br>Participants who will receive English version of evidence summaries | Other: English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)<br>* Participants will receive emails with the link to English version of evidence summaries.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of access to evidence summaries | Total number of access to evidence summaries | Four weeks (28 days) after the commencement of the trial | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Self-rated score of understanding the contents of the provided materials | Five-point Likert scale in understanding the contents of provided materials, evaluated by the participants (higher scores means better outcome) | Within four weeks after the end of intervention | 
| Self-rated score in changing their practice based on the contents of the materials | Five-point Likert scale in changing their practice based on the contents of the materials evaluated by the participants (higher scores means better outcome) | Within four weeks after the end of intervention | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Surveys and Questionnaires, Clinical Competence, Orthopedics, Attitude of Health Personnel, Evidence-based medicine